Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0000905148-26-004079

EVP, Chief Commercial Officer gave up 874 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Santos David A · EVP, Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-01 Shares withheld for taxes : show line 1 in the form −874 $47.50 $41,515 61,622 D
Loading xslF345X06/form4.xml…